Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat anxiety related disorders, including benzodiazepine dependency. It is also developing MM-001, a topical cream formulation of interferon-alpha 2b, which has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation that has completed Phase II clinical trials for the treatment of COVID-19 and other...


CSE:BETR - Post by User

Post by rixpixon Apr 03, 2024 12:45pm
206 Views
Post# 35968022

BETR raises $1.16 Million from convertible debentrues

BETR raises $1.16 Million from convertible debentrues
And these debentures can be converted into units.
Each unit has a 1 share and 1 warrant, both exchangeable @ 10 cents.

If the holders exchange them for shares, another 11.6 MIll shares will go into the total float.
Add another 11.6 mill shares if the warrants get exercized, increasing the total outstanding shares by over 20%. 

But If the SP is not substantially higher than 10 cents by next year, the debenture holders won't exchange it for shares and BETR will have to raise funds again so they can pay these debenture holders, watering down the already high float.

This is what I see, and all is IMHO
GLTA

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities